Persistence Market Research Company
Customize Now Get FREE Sample

Oral Antidiabetic Treatment Market Size, Share, and Growth Forecast, 2026 – 2033

Oral Antidiabetic Treatment Market by Drug Class (Biguanides, Sodium-glucose Co-Transporter-2 (SGLT-2) Inhibitors, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Sulfonylureas, Thiazolidinediones, Meglitinides, Alpha-glucosidase Inhibitors, Others), Route of Administration (Oral, Sublingual, Buccal), End-User (Hospitals, Drug Stores, Pharmacy Stores, Diabetes Treatment Centers, Others), and Regional Analysis for 2026-2033

ID: PMRREP15562| 233 Pages | 10 Feb 2026 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Oral Antidiabetic Treatment Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 – 2033, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-economic Factors
      1. Global Sectoral Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors – Relevance and Impact
  3. Value Added Insights
    1. Tool Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. PESTLE Analysis
    5. Porter’s Five Force Analysis
  4. Price Analysis, 2025A
    1. Key Highlights
    2. Key Factors Impacting Deployment Costs
    3. Pricing Analysis, By Drug Class
  5. Global Oral Antidiabetic Treatment Market Outlook
    1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
    2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2025
      2. Current Market Size (US$ Bn) Analysis and Forecast, 2026 – 2033
    3. Global Oral Antidiabetic Treatment Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Drug Class, 2020 – 2025
      3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2026 – 2033
        1. Biguanides
        2. Sodium-glucose Co-Transporter-2 (SGLT-2) Inhibitors
        3. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
        4. Sulfonylureas
        5. Thiazolidinediones
        6. Meglitinides
        7. Alpha-glucosidase Inhibitors
        8. Others
      4. Market Attractiveness Analysis: Drug Class
    4. Global Oral Antidiabetic Treatment Market Outlook: Route of Administration
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Route of Administration, 2020 – 2025
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
        1. Oral
        2. Sublingual
        3. Buccal
      4. Market Attractiveness Analysis: Route of Administration
    5. Global Oral Antidiabetic Treatment Market Outlook: End-User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End-User, 2020 – 2025
      3. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2026 – 2033
        1. Hospitals
        2. Drug Stores
        3. Pharmacy Stores
        4. Diabetes Treatment Centers
        5. Others
        6. Market Attractiveness Analysis: End-User
  6. Global Oral Antidiabetic Treatment Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2020 – 2025
    3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2026 – 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  7. North America Oral Antidiabetic Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Route of Administration
      4. By End-User
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. U.S.
      2. Canada
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2026 – 2033
      1. Biguanides
      2. Sodium-glucose Co-Transporter-2 (SGLT-2) Inhibitors
      3. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
      4. Sulfonylureas
      5. Thiazolidinediones
      6. Meglitinides
      7. Alpha-glucosidase Inhibitors
      8. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Sublingual
      3. Buccal
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2026-2033
      1. Hospitals
      2. Drug Stores
      3. Pharmacy Stores
      4. Diabetes Treatment Centers
      5. Others
      6. Market Attractiveness Analysis
  8. Europe Oral Antidiabetic Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Route of Administration
      4. By End-User
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2026 – 2033
      1. Biguanides
      2. Sodium-glucose Co-Transporter-2 (SGLT-2) Inhibitors
      3. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
      4. Sulfonylureas
      5. Thiazolidinediones
      6. Meglitinides
      7. Alpha-glucosidase Inhibitors
      8. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Sublingual
      3. Buccal
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2026-2033
      1. Hospitals
      2. Drug Stores
      3. Pharmacy Stores
      4. Diabetes Treatment Centers
      5. Others
    7. Market Attractiveness Analysis
  9. East Asia Oral Antidiabetic Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Route of Administration
      4. By End-User
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. China
      2. Japan
      3. South Korea
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2026 – 2033
      1. Biguanides
      2. Sodium-glucose Co-Transporter-2 (SGLT-2) Inhibitors
      3. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
      4. Sulfonylureas
      5. Thiazolidinediones
      6. Meglitinides
      7. Alpha-glucosidase Inhibitors
      8. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Sublingual
      3. Buccal
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2026-2033
      1. Hospitals
      2. Drug Stores
      3. Pharmacy Stores
      4. Diabetes Treatment Centers
      5. Others
    7. Market Attractiveness Analysis
  10. South Asia & Oceania Oral Antidiabetic Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Route of Administration
      4. By End-User
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2026 – 2033
      1. Biguanides
      2. Sodium-glucose Co-Transporter-2 (SGLT-2) Inhibitors
      3. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
      4. Sulfonylureas
      5. Thiazolidinediones
      6. Meglitinides
      7. Alpha-glucosidase Inhibitors
      8. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Sublingual
      3. Buccal
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2026-2033
      1. Hospitals
      2. Drug Stores
      3. Pharmacy Stores
      4. Diabetes Treatment Centers
      5. Others
    7. Market Attractiveness Analysis
  11. Latin America Oral Antidiabetic Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Route of Administration
      4. By End-User
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2026 – 2033
      1. Biguanides
      2. Sodium-glucose Co-Transporter-2 (SGLT-2) Inhibitors
      3. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
      4. Sulfonylureas
      5. Thiazolidinediones
      6. Meglitinides
      7. Alpha-glucosidase Inhibitors
      8. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Sublingual
      3. Buccal
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2026-2033
      1. Hospitals
      2. Drug Stores
      3. Pharmacy Stores
      4. Diabetes Treatment Centers
      5. Others
    7. Market Attractiveness Analysis
  12. Middle East & Africa Oral Antidiabetic Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Drug Class
      3. By Route of Administration
      4. By End-User
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2026 – 2033
      1. Biguanides
      2. Sodium-glucose Co-Transporter-2 (SGLT-2) Inhibitors
      3. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
      4. Sulfonylureas
      5. Thiazolidinediones
      6. Meglitinides
      7. Alpha-glucosidase Inhibitors
      8. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 – 2033
      1. Oral
      2. Sublingual
      3. Buccal
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-User, 2026-2033
      1. Hospitals
      2. Drug Stores
      3. Pharmacy Stores
      4. Diabetes Treatment Centers
      5. Others
    7. Market Attractiveness Analysis
  13. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
      1. Novo Nordisk A/S
        1. Overview
        2. Segments and Deployments
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Sanofi
      3. AstraZeneca
      4. Merck KGaA
      5. Eli Lilly
      6. Pfizer Inc.
      7. Cipla.
      8. Johnson & Johnson
      9. Sun Pharmaceutical Industries Ltd.
  14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations

 

We use cookies to improve user experience.
Google translate